Innoviva Files for Zoliflodacin, a New Oral Antibiotic for Gonorrhea
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), in collaboration with the Global Antibiotic Research & Development Partnership (GARDP), today announced that...